Type 2 diabetes. Diabetes mellitus due to underlying condition
Conditions
Interventions
Intervention 1: Intervention group: This group will receive the capsules (500 mg) of Urtica Dioica, Vaccinium myrtillus containing 300 mg Urtica Dioica extract and 150 mg of Vaccinium myrtillus extrac
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Type 2 diabetes Taking hypoglycemic drugs (people who control their diabetes just by taking blood sugar-lowering drug) Age 40-70 years Body mass index 18.5–30 kg / m 2 Fasting blood sugar equal to or more than 126 mg / d
Exclusion criteria
Exclusion criteria: Type 1 diabetes Other specific types of diabetes Insulin therapy over the past three months Having serious gastrointestinal diseases (GI) including gastric ulcers and gastrointestinal bleeding Have a history of diabetic ketoacidosis, non-ketotic hyperosmolar diabetic coma, severe infection or surgery in the previous month Uncontrolled high blood pressure (Blood pressure higher or equal to 160/100 mm Hg) mental illness Abuse or addiction to alcohol, psychoactive substances or other drugs Pregnancy, lactation or plan to become pregnant Having cardiovascular disease, renal insufficiency, liver dysfunction, thyroid dysfunction, parathyroid dysfunction, and cancers High physical activity Chronic complications of diabetes (neuropathy, retinopathy, according to patient records), diabetic nephropathy, hypothyroidism and hyperthyroidism Sensitivity to Nettle and Vaccinium myrtillus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: Fasting Blood Sugar Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| HbA1C. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: HbA1C test.;Creatinine. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: Creatinine Test.;Fasting Insulin. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: Fasting Insulin Blood Test.;Cholesterol. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: Cholesterol Test.;Triglyceride. Timepoint: Blood tests before starting the drug and three months later (after taking the drug completely). Method of measurement: Triglyceride Test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMostafa Araj-Khodaei
Tabriz University of Medical Sciences
Outcome results
None listed